Intellia Therapeutics, Inc.
Short
Updated

NTLA: reached key resistance zone

147
Price has followed through strongly from the mid-term support outlined in the September update, moving directly into the target mid-term resistance zone.

As long as the price remains below 30, I expect a near-term pullback below the 21dEMA to complete the first leg of decline.

If, however, the price breaks out above the October highs, it would open the door for further extensions toward the 31–34 resistance zone in the short term.

Chart:
snapshot

Previously:
On bullish trend structure and support zone (Sep 26):
Chart: snapshot
https://www.tradingview.com/symbols/NASDAQ-NTLA/minds/?mind=B8f6LFmoSxGopGg

On resistance zone and pullback potential (Oct 8 and Oct 13):
Chart: snapshot
See weekly review: https://www.tradingview.com/chart/BITF/MXF8r9gK-Weekly-Chart-Review-Oct-6-10-2025/
Trade closed: target reached
That was fast

snapshot

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.